(Press-News.org) PITTSBURGH, Feb. 19, 2013 – A new study published online today in the American Journal of Managed Care found that in Medicare Part D, generic drug coverage was cost-saving compared to no coverage in bipolar disorder and schizophrenia, while also improving health outcomes. Researchers from the University of Pittsburgh School of Medicine, the Pitt Graduate School of Public Health, and Western Psychiatric Institute and Clinic of UPMC note that policymakers and insurers should consider generic-only coverage, rather than no gap coverage, to both conserve health care resources and improve health.
Medicare Part D offers prescription drug coverage for Medicare beneficiaries and since the program's inception in 2006, many enrollees have benefited from improved drug coverage and increased medication use. However, a major concern is the large coverage gap in the standard Part D design, where beneficiaries pay 100 percent of medication costs out-of-pocket. About one-third of all Medicare beneficiaries enter this coverage gap each year, and once there, they often reduce medication use, which may lead to increases in hospitalization and medical spending.
"This coverage gap is an even larger concern for Medicare beneficiaries with severe mental disorders such as bipolar and schizophrenia," said Kenneth J. Smith, M.D., M.S., associate professor of medicine and clinical and translational science at the University of Pittsburgh, and lead author of the study. "Our cost-effectiveness analysis of Part D plans is an unconventional yet instructive way to inform managed care decision-making."
Added concerns for mental health patients include:
Mental health patients are much more likely to enter the "gap:" 62 percent of Medicare beneficiaries with bipolar disorder and 56 percent of those with schizophrenia entered the gap in 2007.
If they discontinue psychotropic medications, they may relapse to more severe episodes and require psychiatric hospitalization.
They experience high rates of comorbid chronic physical conditions such as heart disease and diabetes, which can be exacerbated by untreated mental illness and increase morbidity, medical spending and mortality.
The standard Part D benefit in 2007 included four phases: (1) an initial $265 deductible; (2) a period in which beneficiaries paid 25 percent of drug costs between $265 and $2,400; (3) a coverage gap in which they paid 100 percent of costs between $2,401 and $3,850, where they reached their total out-of-pocket spending catastrophic limit; and (4) a catastrophic coverage period where they paid 5 percent of costs.
Although the standard Part D benefit includes these four phases, some companies offering Part D drug plans modified the design and offered either "actuarially equivalent" or enhanced plans. In 2007, for example, 72 percent of stand-alone Part D plans had the standard coverage gap, 27 percent offered coverage for generic drugs used in the gap, and fewer than 1 percent offered coverage for both brand-name and generic drugs.
"Our objective was to examine differences in health outcomes and costs between coverage groups in patients with bipolar disorder and schizophrenia," added Smith. "We were most interested in differences between the no-gap and generic coverage groups because policies governing the plans' availability and affordability could affect health costs and outcomes for beneficiaries entering the coverage gap."
Of the more than 180,000 patients with bipolar disorder and schizophrenia that were evaluated, 14.6 percent had no gap coverage, and 7.1 percent had generic coverage. The remainder had low-income subsidies with more generous coverage, and therefore, were not strictly comparable to the other two groups. When comparing the no-gap coverage and generic gap coverage groups, patients with generic coverage had better health outcomes and reduced total medical costs as follows:
In disabled recipients with bipolar disorder and no coverage, costs were $570 per person more than generic coverage ($25,090 annually for no gap coverage compared to $24,520 for generic coverage)
In an aged recipient with bipolar disorder and no coverage, costs were $563 more per year than generic coverage
In a disabled recipient with schizophrenia and no coverage, costs were $1,312 more per year than generic coverage
In an aged recipient with schizophrenia and no coverage, costs were $1,289 more per year than generic coverage
Costs were lower with generic coverage due to fewer hospitalizations when this coverage was in place. The authors conclude that generic coverage in the gap is cost-saving compared with no-gap coverage (the standard part D design) and improves health outcomes.
###
Collaborators on this study include Seo Hyon Baik, Ph.D., Charles F. Reynolds III, M.D., Bruce L. Rollman, M.D., M.P.H., and Yuting Zhang, Ph.D., all of the University of Pittsburgh.
This research was supported by the National Institute of Mental Health grant RC1MH088510; the Agency for Healthcare Research and Quality grant R01HS018657; and the University of Pittsburgh Central Research Development Fund.
About the University of Pittsburgh School of Medicine
As one of the nation's leading academic centers for biomedical research, the University of Pittsburgh School of Medicine integrates advanced technology with basic science across a broad range of disciplines in a continuous quest to harness the power of new knowledge and improve the human condition. Driven mainly by the School of Medicine and its affiliates, Pitt has ranked among the top 10 recipients of funding from the National Institutes of Health since 1997. In rankings recently released by the National Science Foundation, Pitt ranked fifth among all American universities in total federal science and engineering research and development support.
Likewise, the School of Medicine is equally committed to advancing the quality and strength of its medical and graduate education programs, for which it is recognized as an innovative leader, and to training highly skilled, compassionate clinicians and creative scientists well-equipped to engage in world-class research. The School of Medicine is the academic partner of UPMC, which has collaborated with the University to raise the standard of medical excellence in Pittsburgh and to position health care as a driving force behind the region's economy. For more information about the School of Medicine, see www.medschool.pitt.edu.
http://www.upmc.com/media
Pitt study examines cost-effectiveness of medicare drug plans in schizophrenia and bipolar disorder
2013-02-20
ELSE PRESS RELEASES FROM THIS DATE:
Using millions of gigs of data to improve human health
2013-02-20
With biomedical scientists struggling to collect and analyze millions of gigabytes of data in their efforts to improve human health, the National Institutes of Health has launched a $700 million project to develop a common data-sharing framework and start training future scientists to tap that gold mine of information. That's the topic of a story in the current edition of Chemical & Engineering News (C&EN), the weekly newsmagazine of the American Chemical Society, the world's largest scientific society.
Britt E. Erickson, C&EN senior editor, explains that biomedical researchers ...
Little did we know about beetle diversity: Astonishing 138 new species in a single genus
2013-02-20
The tropics are home to an extraordinary diversity of insect species. How great is it, exactly? We do not know, but today, researchers at the Santa Barbara Museum of Natural History published a study on tropical beetles that can help us progress towards an answer to this question. The paper was published in the open access, peer-reviewed journal Zookeys.
Entomologists Michael Caterino and Alexey Tishechkin have named 138 new species within the genus Operclipygus (the name refers to their clamshell-like rear end), thereby increasing the size of the genus over six times. ...
Potential benefits of inertial fusion energy justify continued R&D
2013-02-20
WASHINGTON -- The potential benefits of successful development of an inertial confinement fusion-based energy technology justify investment in fusion energy research and development as part of the long-term U.S. energy R&D portfolio, says a new report from the National Research Council. Although ignition of the fusion fuel has not yet been achieved, scientific and technological progress in inertial confinement fusion over the past decade has been substantial. Developing inertial fusion energy would require establishment of a national, coordinated, broad-based program, ...
Molecules assemble in water, hint at origins of life
2013-02-20
The base pairs that hold together two pieces of RNA, the older cousin of DNA, are some of the most important molecular interactions in living cells. Many scientists believe that these base pairs were part of life from the very beginning and that RNA was one of the first polymers of life. But there is a problem. The RNA bases don't form base pairs in water unless they are connected to a polymer backbone, a trait that has baffled origin-of-life scientists for decades. If the bases don't pair before they are part of polymers, how would the bases have been selected out from ...
Being stoic for the spouse's sake comes at a high cost
2013-02-20
Among life's many tragedies, the death of a child is one that is perhaps the greatest for parents. No matter what the age of the child or the cause of death, the irrefutable fact of the loss is one that shatters the normal cycle of life, leaving parents traumatized and often incapacitated by grief.
Research on coping with bereavement has focused primarily on the individual, despite the fact that family and married relationships are all profoundly disrupted by the loss. But in the wealth of studies about parental grief, little attention has been paid to precisely how couples ...
Study: Resveratrol shows promise to protect hearing, cognition
2013-02-20
DETROIT – Resveratrol, a substance found in red grapes and red wine, may have the potential to protect against hearing and cognitive decline, according to a published laboratory study from Henry Ford Hospital in Detroit.
The study shows that healthy rats are less likely to suffer the long-term effects of noise-induced hearing loss when given resveratrol before being exposed to loud noise for a long period of time.
"Our latest study focuses on resveratrol and its effect on bioinflammation, the body's response to injury and something that is believed to be the cause of ...
Children with brain lesions able to use gestures important to language learning
2013-02-20
ATLANTA – Children with brain lesions suffered before or around the time of birth are able to use gestures – an important aspect of the language learning process– to convey simple sentences, a Georgia State University researcher has found.
Şeyda Özçalışkan, assistant professor of psychology, and fellow researchers at the University of Chicago, looked at children who suffered lesions to one side of the brain to see whether they used gestures similar to typically developing children. She examined gestures such as pointing to a cookie while saying "eat" to ...
The ethics of access: Comparing 2 federal health care reform efforts
2013-02-20
ANN ARBOR, Mich. — Two major health reform laws, enacted 25 years apart, both try to meet an ethical standard to provide broad access to basic health care. Neither quite gets there -- but it's not too late for modern health care reform to bring the nation closer to a goal of comprehensive and coordinated care for all.
That's the conclusion of a commentary published in the new issue of the Journal of the American Medical Association by a team of University of Michigan Health System physicians.
The authors – a family physician, an emergency physician and a primary care ...
Smoking cessation in old age: Less heart attacks and strokes within 5 years
2013-02-20
Professor Hermann Brenner and colleagues analyzed the data of 8.807 individuals aged between 50 and 74 years using data of Saarland citizens. "We were able to show that the risk of smokers for cardiovascular diseases is more than twice that of non-smokers. However, former smokers are affected at almost the same low rate as people of the same age who never smoked," says Brenner. "Moreover, smokers are affected at a significantly younger age than individuals who have never smoked or have stopped smoking." For example, a 60-year-old smoker has the same risk of myocardial infarction ...
Setting the record straight on Medicare's overhead costs: New study
2013-02-20
The traditional Medicare program allocates only 1 percent of total spending to overhead compared with 6 percent when the privatized portion of Medicare, known as Medicare Advantage, is included, according to a study in the June 2013 issue of the Journal of Health Politics, Policy and Law.
The 1 percent figure includes all types of non-medical spending by the Centers for Medicare and Medicaid Services plus other federal agencies, such as the IRS, that support the Medicare program, and is based on data contained in the latest report of the Medicare trustees. The 6 percent ...